Skip to content

A randomised controlled trial, comparing Surgical Decompression with an Interspinous Implant in patients with Intermittent Neurogenic Claudication caused by Lumbar Stenosis.

A randomised controlled trial, comparing Surgical Decompression with an Interspinous Implant in patients with Intermittent Neurogenic Claudication caused by Lumbar Stenosis. - The Felix trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON31834
Enrollment
386
Registered
2008-04-15
Start date
2009-05-15
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal stenosis & pressure on the nerves causing leg pain

Interventions

Surgical intervention with the Coflex device.

Sponsors

Paradigm Spine / InSpine
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: signed informed consent - is 45 - 80 years old at time of surgery - has intermittent neurogenic claudicatio - has received at least three months of conservative care therapy - has a regular indication for surgical intervention of INC - has a narrowed lumbar spinal canal, nerve root canal or intervertebral foramen at one or two levels confirmed by MRI - is physically and mentally willing and able to comply with the post-operative evaluations.

Exclusion criteria

Exclusion criteria: - has cauda equina syndrome - has Paget's disease, severe osteoporosis or metastasis to the vertebrae - has significant scoliosis - has a BMI > 40 kg/m2 - has had any surgery of the lumbar spine - has degenerative spondylolisthesis > grade 1 (on a scale 1 to 4) - has significant instability of the lumbar spine - has severe comorbid conditions - has a fused segment at the indicated level

Design outcomes

Primary

MeasureTime frame
Symptoms and patient satisfaction will be measured with the Zurich Claudication Questionnaire.

Secondary

MeasureTime frame
The cost effectiveness as measured by the EuroQol questionnaire and costs obtained from the patient's diary.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)